Abstract Submission is closed.

We received 405 abstract submissions (27 of them late-breaking). Late-breaking abstracts are still being reviewed/scored. Abstracts will not be published online until May 22, 2022— one week before the start of the symposium.

Please be assured: The health and safety of our attendees, corporate partners, and meeting organizers are very important to the SRS. We expect that the recent emergence of the Omicron variant of COVID-19 will only be a winter concern and will cease in the warmer spring season. Full vaccination will be required for attendance, and organizers will be taking other steps to ensure a safe, informative, and fun symposium.

Organizers strongly encouraged colleagues to refer to the Consensus nomenclature rules for radiopharmaceutical chemistry – setting the record straight. This important guide was developed by an international working group in order to promote the clear and appropriate use of terms and to provide consensus on the utilization of a standardized nomenclature pertinent to the field.

Below is the list of abstract categories:

  • 11C - Radiochemistry
  • 18F - Radiochemistry
  • Radiometals - Chemistry
  • Applications of radiolabeled compounds in oncology
  • Applications of radiolabeled compounds in neurosciences
  • Applications of radiolabeled compounds in other fields (cardiology, infection, inflammation, etc.)
  • Automation / Microfluidics /Process Development
  • Multimodality Imaging Probes
  • Nanomedicine
  • New biological vectors inradiopharmaceutical sciences and bioconjugation strategies
  • New imaging techniques
  • Radiopharmacy
  • Targetry
  • Theranostics
  • Miscellaneous